vs
Assertio Holdings, Inc.（ASRT）与ESPEY MFG & ELECTRONICS CORP（ESP）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是ESPEY MFG & ELECTRONICS CORP的1.1倍（$13.5M vs $12.1M），ESPEY MFG & ELECTRONICS CORP同比增速更快（-10.8% vs -57.9%），过去两年ESPEY MFG & ELECTRONICS CORP的营收复合增速更高（21.3% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Espey制造电子公司是总部位于美国的制造商，专注于高可靠性电源、电力转换系统及专用电子元件的设计生产，面向航空航天、国防、工业及交通领域，为北美及部分国际市场客户提供适配恶劣运行环境的定制化解决方案。
ASRT vs ESP — 直观对比
营收规模更大
ASRT
是对方的1.1倍
$12.1M
营收增速更快
ESP
高出47.1%
-57.9%
两年增速更快
ESP
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $12.1M |
| 净利润 | — | $2.8M |
| 毛利率 | — | 34.7% |
| 营业利润率 | -86.7% | 25.3% |
| 净利率 | — | 23.1% |
| 营收同比 | -57.9% | -10.8% |
| 净利润同比 | — | 47.0% |
| 每股收益（稀释后） | $-4.54 | $0.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTESP
| Q4 25 | $13.5M | $12.1M | ||
| Q3 25 | $49.5M | $9.1M | ||
| Q2 25 | $29.2M | $9.6M | ||
| Q1 25 | $26.5M | $10.3M | ||
| Q4 24 | $32.2M | $13.6M | ||
| Q3 24 | $29.2M | $10.4M | ||
| Q2 24 | $31.1M | $11.6M | ||
| Q1 24 | $32.4M | $8.3M |
净利润ASRTESP
| Q4 25 | — | $2.8M | ||
| Q3 25 | $11.4M | $2.2M | ||
| Q2 25 | $-16.4M | $2.9M | ||
| Q1 25 | $-13.5M | $1.7M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $-2.9M | $1.6M | ||
| Q2 24 | $-3.7M | $1.9M | ||
| Q1 24 | $-4.5M | $1.0M |
毛利率ASRTESP
| Q4 25 | — | 34.7% | ||
| Q3 25 | — | 35.4% | ||
| Q2 25 | — | 39.3% | ||
| Q1 25 | — | 28.6% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 26.8% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | 25.0% |
营业利润率ASRTESP
| Q4 25 | -86.7% | 25.3% | ||
| Q3 25 | 23.2% | 22.7% | ||
| Q2 25 | -27.5% | 27.4% | ||
| Q1 25 | -50.0% | 17.0% | ||
| Q4 24 | -41.9% | 14.9% | ||
| Q3 24 | -10.4% | 16.5% | ||
| Q2 24 | -11.6% | 18.4% | ||
| Q1 24 | -13.4% | 13.2% |
净利率ASRTESP
| Q4 25 | — | 23.1% | ||
| Q3 25 | 23.1% | 23.9% | ||
| Q2 25 | -56.0% | 30.6% | ||
| Q1 25 | -51.1% | 16.5% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | -10.0% | 15.3% | ||
| Q2 24 | -11.8% | 16.3% | ||
| Q1 24 | -13.9% | 12.5% |
每股收益（稀释后）ASRTESP
| Q4 25 | $-4.54 | $0.99 | ||
| Q3 25 | $0.11 | $0.76 | ||
| Q2 25 | $-0.17 | $1.07 | ||
| Q1 25 | $-0.14 | $0.63 | ||
| Q4 24 | $-3.28 | $0.71 | ||
| Q3 24 | $-0.03 | $0.61 | ||
| Q2 24 | $-0.04 | $0.73 | ||
| Q1 24 | $-0.05 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $17.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $53.2M |
| 总资产 | $267.0M | $85.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTESP
| Q4 25 | $63.4M | $17.8M | ||
| Q3 25 | $93.4M | $22.2M | ||
| Q2 25 | $98.2M | $18.9M | ||
| Q1 25 | $87.3M | $13.9M | ||
| Q4 24 | $100.1M | $8.0M | ||
| Q3 24 | $88.6M | $4.8M | ||
| Q2 24 | $88.4M | $4.4M | ||
| Q1 24 | $80.7M | $5.6M |
总债务ASRTESP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTESP
| Q4 25 | $94.0M | $53.2M | ||
| Q3 25 | $105.8M | $51.0M | ||
| Q2 25 | $93.3M | $50.8M | ||
| Q1 25 | $108.5M | $46.3M | ||
| Q4 24 | $121.1M | $44.8M | ||
| Q3 24 | $130.5M | $42.5M | ||
| Q2 24 | $132.2M | $41.3M | ||
| Q1 24 | $134.5M | $39.3M |
总资产ASRTESP
| Q4 25 | $267.0M | $85.2M | ||
| Q3 25 | $319.8M | $84.8M | ||
| Q2 25 | $273.8M | $79.1M | ||
| Q1 25 | $286.4M | $72.8M | ||
| Q4 24 | $284.7M | $60.2M | ||
| Q3 24 | $276.0M | $57.6M | ||
| Q2 24 | $279.4M | $56.5M | ||
| Q1 24 | $282.0M | $53.1M |
负债/权益比ASRTESP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-2.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-4.1M |
| 自由现金流率自由现金流/营收 | — | -34.1% |
| 资本支出强度资本支出/营收 | — | 10.9% |
| 现金转化率经营现金流/净利润 | — | -1.00× |
| 过去12个月自由现金流最近4个季度 | — | $11.7M |
8季度趋势，按日历期对齐
经营现金流ASRTESP
| Q4 25 | $-30.0M | $-2.8M | ||
| Q3 25 | $-4.8M | $5.7M | ||
| Q2 25 | $19.1M | $2.8M | ||
| Q1 25 | $-12.5M | $11.5M | ||
| Q4 24 | $11.5M | $5.4M | ||
| Q3 24 | $-35.0K | $1.4M | ||
| Q2 24 | $7.4M | $3.2M | ||
| Q1 24 | $7.5M | $1.4M |
自由现金流ASRTESP
| Q4 25 | — | $-4.1M | ||
| Q3 25 | — | $4.4M | ||
| Q2 25 | — | $915.3K | ||
| Q1 25 | — | $10.5M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $724.8K | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $379.1K |
自由现金流率ASRTESP
| Q4 25 | — | -34.1% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 101.8% | ||
| Q4 24 | — | 33.0% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | 22.2% | ||
| Q1 24 | — | 4.6% |
资本支出强度ASRTESP
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | 19.3% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | 0.0% | 6.4% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 12.5% |
现金转化率ASRTESP
| Q4 25 | — | -1.00× | ||
| Q3 25 | -0.42× | 2.64× | ||
| Q2 25 | — | 0.95× | ||
| Q1 25 | — | 6.72× | ||
| Q4 24 | — | 2.82× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 1.71× | ||
| Q1 24 | — | 1.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
ESP
| ASC606 | $11.3M | 93% |
| Other | $855.0K | 7% |
